$51.85
-0.14-0.26%
Last update: Nov 11, 1:54 PM
Travere Therapeutics Inc
TVTXNASDAQ
The average analyst price target for Travere Therapeutics is $56.24, 8.5% above the current price. Of 15 analysts, 13 rate it Buy and 2 Hold. Targets range from $20 to $86. The latest change came on Nov 6, 2026, when JP Morgan lowered its price target on Travere Therapeutics from $90 to $86 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
